New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Stem Cell Therapy for PPMS: Treatments, Research & Benefits

Stem Cell Therapy for PPMS: Treatments, Research & Benefits

Stem Cell Therapy for PPMS: Treatments, Research & BenefitsBy:Louis A. Cona, MDReviewed:Robert J. HancockDiscover the latest advancements in managing primary progressive multiple sclerosis (PPMS),
Stem cells February 02,2024
Stem Cell Therapy for PPMS: Treatments, Research & Benefits

Stem Cell Therapy for PPMS: Treatments, Research & Benefits

Stem Cell Therapy for PPMS: Treatments, Research & BenefitsBy:Louis A. Cona, MDReviewed:Robert J. HancockDiscover the latest advancements in managing primary progressive multiple sclerosis (PPMS),
Stem cells February 02,2024
Best Natural Treatments for Multiple Sclerosis

Best Natural Treatments for Multiple Sclerosis

Best Natural Treatments for Multiple Sclerosis (2023)By:Louis A. Cona, MDReviewed:Robert J. HancockDiscover the latest breakthroughs in natural treatments for Multiple Sclerosis, including stem cell t
Stem cells February 02,2024
Best Natural Treatments for Multiple Sclerosis

Best Natural Treatments for Multiple Sclerosis

Best Natural Treatments for Multiple Sclerosis (2023)By:Louis A. Cona, MDReviewed:Robert J. HancockDiscover the latest breakthroughs in natural treatments for Multiple Sclerosis, including stem cell t
Stem cells February 02,2024
Stem Cell Therapy for Hashimoto's Thyroiditis: Benefits and Risks

Stem Cell Therapy for Hashimoto's Thyroiditis: Benefits and Risks

Stem Cell Therapy for Hashimoto's Thyroiditis: Benefits and Risks (2023)By:Louis A. Cona, MDReviewed:Robert J. HancockDiscover the potential of mesenchymal stem cell therapy for Hashimoto's th
Stem cells February 02,2024
Stem Cell Therapy for Hashimoto's Thyroiditis: Benefits and Risks

Stem Cell Therapy for Hashimoto's Thyroiditis: Benefits and Risks

Stem Cell Therapy for Hashimoto's Thyroiditis: Benefits and Risks (2023)By:Louis A. Cona, MDReviewed:Robert J. HancockDiscover the potential of mesenchymal stem cell therapy for Hashimoto's th
Stem cells February 02,2024
INSIGHT of Medicine(phase 4,2024)

INSIGHT of Medicine(phase 4,2024)

1.A single-cell atlas of IL-23 inhibition in cutaneous psoriasis distinguishes clinical responseThe exact etiology of psoriasis remains elusive. However, there is compelling evidence to suggest that b
Insight Medicine February 01,2024
INSIGHT of Medicine(phase 4,2024)

INSIGHT of Medicine(phase 4,2024)

1.A single-cell atlas of IL-23 inhibition in cutaneous psoriasis distinguishes clinical responseThe exact etiology of psoriasis remains elusive. However, there is compelling evidence to suggest that b
Insight Medicine February 01,2024
A novel strategy to suppress triple negative breast cancer growth

A novel strategy to suppress triple negative breast cancer growth

by Homa Shalchi,Baylor College of MedicineCredit:PLOS Biology(2023). DOI: 10.1371/journal.pbio.3002227In 2022, a team of researchers at Baylor College of Medicinediscovered&nbs
Oncology February 01,2024
A novel strategy to suppress triple negative breast cancer growth

A novel strategy to suppress triple negative breast cancer growth

by Homa Shalchi,Baylor College of MedicineCredit:PLOS Biology(2023). DOI: 10.1371/journal.pbio.3002227In 2022, a team of researchers at Baylor College of Medicinediscovered&nbs
Oncology February 01,2024
Research team explores 'treasures' from discarded data in cancer research

Research team explores 'treasures' from discarded data in cancer research

by OncotargetMost abundant bacteria taxa found in bladder analysis. In (A), relative genus abundance among samples. In (B), presence/absence Venn diagram: Bladder cancer tissue metagenomic profile obt
Oncology February 01,2024
Research team explores 'treasures' from discarded data in cancer research

Research team explores 'treasures' from discarded data in cancer research

by OncotargetMost abundant bacteria taxa found in bladder analysis. In (A), relative genus abundance among samples. In (B), presence/absence Venn diagram: Bladder cancer tissue metagenomic profile obt
Oncology February 01,2024
Study identifies new test to accurately predict end of life for lung cancer patients

Study identifies new test to accurately predict end of life for lung cancer patients

by University of LiverpoolVOCs that increase towards death in the acid dataset. Jitter box plot graph for each metabolite identified as significant from univariate and linear regression analysis.
Oncology February 01,2024
Study identifies new test to accurately predict end of life for lung cancer patients

Study identifies new test to accurately predict end of life for lung cancer patients

by University of LiverpoolVOCs that increase towards death in the acid dataset. Jitter box plot graph for each metabolite identified as significant from univariate and linear regression analysis.
Oncology February 01,2024
Study unveils molecular pathways followed by metastatic cancer cells

Study unveils molecular pathways followed by metastatic cancer cells

by Baylor College of MedicineCredit: Unsplash/CC0 Public DomainMetastasis, the process by which cancer cells leave the primary tumor and spread to other tissues to seed new cancerous growth, caus
Oncology February 01,2024
Study unveils molecular pathways followed by metastatic cancer cells

Study unveils molecular pathways followed by metastatic cancer cells

by Baylor College of MedicineCredit: Unsplash/CC0 Public DomainMetastasis, the process by which cancer cells leave the primary tumor and spread to other tissues to seed new cancerous growth, caus
Oncology February 01,2024
Preventing 'chemo brain' with antioxidants targeting the spinal fluid

Preventing 'chemo brain' with antioxidants targeting the spinal fluid

by Children's Hospital BostonGraphical abstract. Credit:Neuron(2022). DOI: 10.1016/j.neuron.2022.08.009Up to three quarters of patients receiving cancer chemotherapy suffer from &
Oncology February 01,2024
Preventing 'chemo brain' with antioxidants targeting the spinal fluid

Preventing 'chemo brain' with antioxidants targeting the spinal fluid

by Children's Hospital BostonGraphical abstract. Credit:Neuron(2022). DOI: 10.1016/j.neuron.2022.08.009Up to three quarters of patients receiving cancer chemotherapy suffer from &
Oncology February 01,2024
Immunotherapy before surgery induces complete response in more than half of patients with common skin cancer

Immunotherapy before surgery induces complete response in more than half of patients with common skin cancer

by University of Texas M. D. Anderson Cancer CenterCredit: CC0 Public DomainIn an international, multicenter Phase II clinical trial led by The University of Texas MD Anderson Cancer Center, 63.3
Oncology February 01,2024
Immunotherapy before surgery induces complete response in more than half of patients with common skin cancer

Immunotherapy before surgery induces complete response in more than half of patients with common skin cancer

by University of Texas M. D. Anderson Cancer CenterCredit: CC0 Public DomainIn an international, multicenter Phase II clinical trial led by The University of Texas MD Anderson Cancer Center, 63.3
Oncology February 01,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com